• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.

作者信息

Paquet P, Nikkels A, Arrese J E, Vanderkelen A, Piérard G E

机构信息

Department of Dermatopathology, University of Liège, Belgium.

出版信息

Arch Dermatol. 1994 May;130(5):605-8.

PMID:8179342
Abstract

BACKGROUND

We studied the immunopathologic characteristics of five cases of toxic epidermal necrolysis by using a large panel of antibodies.

OBSERVATIONS

The pattern and amount of the inflammatory cell infiltrate varied according to the stage of the disease. The main constant feature was the prominent involvement of the monocyte-macrophage lineage, including factor XIIIa+HLA-DR+ dendrocytes and CD68+ Mac 387+ macrophages, before and during the epidermal necrosis. The number of CD4+ and CD8+ lymphocytes was comparatively small. This was associated with a dense labeling of the epidermis for tumor necrosis factor alpha.

CONCLUSIONS

Cells of the monocyte-macrophage lineage largely outnumber lymphocytes in the lesions of toxic epidermal necrolysis. Tumor necrosis factor alpha is likely a major cytokine that is responsible for necrosis.

摘要

相似文献

1
Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.
Arch Dermatol. 1994 May;130(5):605-8.
2
Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association.
Int J Mol Med. 2005 Jul;16(1):29-33.
3
Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.卡马西平诱导中毒性表皮坏死松解症的机制研究
Arch Dermatol. 1994 May;130(5):598-604.
4
Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.药物性中毒性表皮坏死松解症治疗期间炎症细胞浸润及CD95R表达的分析定量
Arch Dermatol Res. 2005 Dec;297(6):266-73. doi: 10.1007/s00403-005-0607-3. Epub 2005 Oct 25.
5
Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case.中毒性表皮坏死松解症中的淋巴细胞亚群和朗格汉斯细胞。病例报告。
Arch Dermatol. 1986 Apr;122(4):455-8.
6
T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.药物性中毒性表皮坏死松解症中的T细胞亚群。CD8阳性T细胞诱导的可能致病机制。
Arch Dermatol. 1991 Jun;127(6):851-5.
7
The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.CD40/CD40配体系统在多形红斑及史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症谱系的皮肤损害中表达。
Br J Dermatol. 2006 Feb;154(2):319-24. doi: 10.1111/j.1365-2133.2005.07023.x.
8
Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement.中毒性表皮坏死松解症中的皮肤T细胞募集。CD8 +淋巴细胞参与的进一步证据。
Arch Dermatol. 1993 Apr;129(4):466-8.
9
Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis.
Am J Dermatopathol. 2000 Oct;22(5):413-7. doi: 10.1097/00000372-200010000-00005.
10
Impaired antigen presentation in toxic epidermal necrolysis.
Arch Dermatol. 1993 Jun;129(6):721-7.

引用本文的文献

1
Inhibition of formyl peptide receptor-1-mediated cell death as a therapy for lethal cutaneous drug reactions in preclinical models.在临床前模型中,抑制甲酰肽受体-1介导的细胞死亡作为致死性皮肤药物反应的一种治疗方法。
Nat Commun. 2025 Sep 30;16(1):8708. doi: 10.1038/s41467-025-63744-0.
2
Effect of Diet Compositions on Colony Strength Parameters, and the Enzymatic Activity of L. During Floral Scarcity.花期食物匮乏期间,日粮组成对蜂群强度参数及意大利蜜蜂酶活性的影响。
Insects. 2025 Sep 16;16(9):967. doi: 10.3390/insects16090967.
3
Allopurinol: Clinical Considerations in the Development and Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Other Associated Drug Reactions.
别嘌醇:史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症及其他相关药物反应的发生发展与治疗中的临床考量
Cureus. 2024 Jul 16;16(7):e64654. doi: 10.7759/cureus.64654. eCollection 2024 Jul.
4
Positive experience with TNF-α inhibitor in toxic epidermal necrolysis resistant to high-dose systemic corticosteroids.肿瘤坏死因子-α抑制剂治疗大剂量全身糖皮质激素抵抗的中毒性表皮坏死松解症的阳性经验。
Front Med (Lausanne). 2023 Jul 24;10:1210026. doi: 10.3389/fmed.2023.1210026. eCollection 2023.
5
Current Perspectives on Severe Drug Eruption.当前对严重药物疹的看法。
Clin Rev Allergy Immunol. 2021 Dec;61(3):282-298. doi: 10.1007/s12016-021-08859-0. Epub 2021 Jul 17.
6
Understanding Immune Responses to Surgical Transplant Procedures in Stevens Johnsons Syndrome Patients.了解史蒂文斯-约翰逊综合征患者对外科移植手术的免疫反应。
Front Med (Lausanne). 2021 May 21;8:656998. doi: 10.3389/fmed.2021.656998. eCollection 2021.
7
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症管理与认识的最新进展
F1000Res. 2020 Jun 16;9. doi: 10.12688/f1000research.24748.1. eCollection 2020.
8
Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).严重皮肤不良反应表皮坏死松解症(EN)的临床和发病方面。
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1957-1971. doi: 10.1111/jdv.16339. Epub 2020 May 15.
9
Bullous Drug Reactions.大疱性药物不良反应。
Acta Derm Venereol. 2020 Feb 12;100(5):adv00057. doi: 10.2340/00015555-3408.
10
An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.药物过敏反应的分子机制最新研究综述
J Immunol Res. 2018 Feb 13;2018:6431694. doi: 10.1155/2018/6431694. eCollection 2018.